Literature DB >> 34050962

Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in Diffuse Large B-cell Lymphoma; caution required.

Nicolas Martinez-Calle1, Matthew R Wilson2, Toby A Eyre3, Kate Cwynarski4, Pamela McKay2, Christopher P Fox1,5.   

Abstract

Entities:  

Year:  2021        PMID： 34050962     DOI： 10.1002/ajh.26257

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas.

Authors:  Megan Fleming; Ying Huang; Emily Dotson; David A Bond; John Reneau; Narendranath Epperla; Lapo Alinari; Jonathan Brammer; Beth A Christian; Robert A Baiocchi; Kami Maddocks; Yazeed Sawalha
Journal:  Blood Adv       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.